Related references
Note: Only part of the references are listed.Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani
Jade-Eva Potvin et al.
CLINICAL INFECTIOUS DISEASES (2021)
The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression
Baibaswata Saha et al.
CYTOKINE (2021)
Unveiling six potent and highly selective antileishmanial agents via the open source compound collection 'Pathogen Box' against antimony-sensitive and -resistant Leishmania braziliensis
Juliano A. Souza Silva et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Comparative transcriptomic analysis of antimony resistant and susceptible Leishmania infantum lines
Juvana Moreira Andrade et al.
PARASITES & VECTORS (2020)
An integrative approach using systems biology, mutational analysis with molecular dynamics simulation to challenge the functionality of a target protein
Nikita Bora et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
From biophysics to omics and systems biology
Marko Djordjevic et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2019)
Leishmaniasis in humans: drug or vaccine therapy?
Masoud Ghorbani et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Building protein-protein interaction networks for Leishmania species through protein structural information
Crhisllane Rafaele dos Santos Vasconcelos et al.
BMC BIOINFORMATICS (2018)
Leishmaniasis treatment: update of possibilities for drug repurposing
Valter Viana Andrade-Neto et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Transcription Factor Target Gene Network governs the Logical Abstraction Analysis of the Synthetic Circuit in Leishmaniasis
Milsee Mol et al.
SCIENTIFIC REPORTS (2018)
Ascorbate peroxidase overexpression protects Leishmania braziliensis against trivalent antimony effects
Douglas de Souza Moreira et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2018)
Quantification of non-coding RNA target localization diversity and its application in cancers
Lixin Cheng et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2018)
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
Saumya Srivastava et al.
PARASITES & VECTORS (2017)
Gene Expression in Leishmania Is Regulated Predominantly by Gene Dosage
Stefano A. Iantorno et al.
MBIO (2017)
HISP: a hybrid intelligent approach for identifying directed signaling pathways
Xing-Ming Zhao et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2017)
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Alicia Ponte-Sucre et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
Nayara Castelano Brito et al.
PLOS ONE (2017)
Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines
Douglas de Souza Moreira et al.
EXPERIMENTAL PARASITOLOGY (2016)
Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
Annelies Mondelaers et al.
PLOS ONE (2016)
Functional analysis of iron superoxide dismutase-A in wild-type and antimony-resistant Leishmania braziliensis and Leishmania infantum lines
N. G. Tessarollo et al.
PARASITOLOGY INTERNATIONAL (2015)
Phosphoproteomic analysis of wild-type and antimony-resistant Leishmania braziliensis lines by 2D-DIGE technology
Douglas de Souza Moreira et al.
PROTEOMICS (2015)
Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study
Meghan R. Perry et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani
Vasundhra Bhandari et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum lines
Juvana M. Andrade et al.
PARASITES & VECTORS (2014)
The Genome Sequence of Leishmania (Leishmania) amazonensis: Functional Annotation and Extended Analysis of Gene Models
Fernando Real et al.
DNA RESEARCH (2013)
Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines
Fabiana S. V. Matrangolo et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2013)
Proteomic and Genomic Analyses of Antimony Resistant Leishmania infantum Mutant
Marie-Christine Brotherton et al.
PLOS ONE (2013)
In vitro Antileishmanial Drug Susceptibility of Clinical Isolates from Patients with Indian Visceral Leishmaniasis-Status of Newly Introduced Drugs
Vijay Kumar Prajapati et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
Bidyut Purkait et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Schistosoma mansoni phylome: using evolutionary genomics to gain insight into a parasite's biology
Larissa Lopes Silva et al.
BMC GENOMICS (2012)
Liposomal amphotericin B as a treatment for human leishmaniasis
Manica Balasegaram et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Greater binding affinity of trivalent antimony to a CCCH zinc finger domain compared to a CCHC domain of kinetoplastid proteins
Frederic Frezard et al.
METALLOMICS (2012)
Computational Prediction of Protein-Protein Interactions in Leishmania Predicted Proteomes
Antonio M. Rezende et al.
PLOS ONE (2012)
Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani
Neha Biyani et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani
Awanish Kumar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Taking a Systems Approach to the Identification of Novel Therapeutic Targets and Biomarkers
David A. Dunn et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India
Swati Mandal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Drug Resistance in Visceral Leishmaniasis
Helena C. Maltezou
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial
Asrat Hailu et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Philosophical Basis and Some Historical Aspects of Systems Biology: From Hegel to Noble - Applications for Bioenergetic Research
Valdur Saks et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials
Susan Wyllie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evolutionary conservation of RNA editing in the genus Leishmania
Muntaser E. Ibrahim et al.
INFECTION GENETICS AND EVOLUTION (2008)
Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major
Arvind K. Chavali et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Leishmania:: conserved evolution -: diverse diseases
Miriam A. Lynn et al.
TRENDS IN PARASITOLOGY (2008)
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo
Karin Seifert et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Comparative genomic analysis of three Leishmania species that cause diverse human disease
Christopher S. Peacock et al.
NATURE GENETICS (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Miltefosine afects lipid metabolism in Leishmania donovani promastigotes
M. Rakotomanga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Characterization of natural antimony resistance in Leishmania donovani isolates
Mukul K. Mittal et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani
Angana Mukherjee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
A proteomics screen implicates HSP83 and a small kinetoplastid calpain- related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death
Baptiste Vergnes et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Oral miltefosine for the treatment of Indian visceral leishmaniasis
Shyam Sundar et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Metabolic functions of glycosornes in trypanosomatids
Paul A. M. Michels et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites
F. Javier Perez-Victoria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Genomes, phylogeny, and evolutionary systems biology
M Medina
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Systems biology in drug discovery
EC Butcher et al.
NATURE BIOTECHNOLOGY (2004)
Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani
S Wyllie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes
G Sudhandiran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Drug resistance in Indian visceral leishmaniasis
S Sundar
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes
D Sereno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
